Whey Protein Supplementation Improves the Glycemic Response and May Reduce Non-Alcoholic Fatty Liver Disease Related Biomarkers in Women with Polycystic Ovary Syndrome (PCOS)

Whey Protein Supplementation Improves the Glycemic Response and May Reduce Non-Alcoholic Fatty Liver Disease Related Biomarkers in Women with Polycystic Ovary Syndrome (PCOS)

Polycystic ovary syndrome (PCOS) increases type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) with insulin resistance. We hypothesized that a 35 g whey preload would improve insulin sensitivity and glucose handling while reducing biomarkers associated with NAFLD. Twenty-nine age-matched w...

Full description

Bibliographic Details
Main Authors: Emily L. Zumbro, Manisha Rao, Shenavia Balcom-Luker, K. Shane Broughton, Monique J. LeMieux
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Nutrients
Subjects:
polycystic ovary syndrome
sex hormone-binding globulin
non-alcoholic fatty liver disease
whey proteins
blood glucose
exploratory study
Online Access:https://www.mdpi.com/2072-6643/13/7/2451

Similar Items

Similar Items